Accession Number : AD0697657
Title : EFFECTS OF OUABAIN ON THE SPLANCHNIC CIRCULATION.
Descriptive Note : Technical rept.,
Corporate Author : OKLAHOMA UNIV MEDICAL CENTER OKLAHOMA CITY
Personal Author(s) : Harrison,Lura Ann ; Blaschke,Jon ; Phillips,Robert S. ; Price,William E. ; Cotten,Marion deV.
Report Date : 14 NOV 1969
Pagination or Media Count : 25
Abstract : Previous investigations have suggested that administration of cardiac glycosides to the normal dog results in sequestration of blood in the splanchnic bed which diminishes the venous return and cardiac output. The aim of this study was to evaluate and quantify splanchnic hemodynamic changes due to administration of ouabain. The dogs were anesthetized with chloralose and urethane. Direct measurements of mesenteric artery and splenic artery blood flow were obtained with electromagnetic blood flow transducers; systemic arterial and portal venous pressures with strain gauge transducers; intestinal and splenic weight changes with a strain gauge weighing devicel and liver blood volume with l131 -albumin injection and punch biopsies. These parameters were monitored before and after injection of ouabain. We found the following responses to ouabain: (1) significant increases in systemic arterial pressure and calculated splenic and mesenteric vascular resistances, and (2) no significant changes in portal venous pressure, splenic or mesenteric blood flow, organ weights or liver blood volume. From these findings we conclude that there is no evidence for splanchnic congestion with therapeutic doses of ouabain and that the ma or splanchnic vascular event induced by ouabain is arteriolar vasoconstriction. (Author)
Descriptors : (*CARDIAC GLYCOSIDES, *BLOOD CIRCULATION), (*VASOACTIVE AGENTS, CARDIAC GLYCOSIDES), BLOOD VOLUME, MEASUREMENT, INTESTINES, RESPONSE(BIOLOGY), LIVER, CONTRACTION, BLOOD VESSELS, BLOOD PRESSURE, DOSAGE, LABELED SUBSTANCES
Subject Categories : Pharmacology
Distribution Statement : APPROVED FOR PUBLIC RELEASE